Literature DB >> 25822445

The relationship between inflammatory bowel disease and type 1 diabetes mellitus: a study of relative prevalence in comparison with population controls.

Hugo A Penny1, John S Leeds2, Matthew Kurien2, Anastasios Averginos2, Andrew D Hopper2, Marios Hadjivassiliou3, Solomon Tesfaye4, David S Sanders2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25822445

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN： 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  4 in total

1.  Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Ninna H Tougaard; Marie Frimodt-Møller; Hanne Salmenkari; Elisabeth B Stougaard; Andressa D Zawadzki; Ismo M Mattila; Tine W Hansen; Cristina Legido-Quigley; Sohvi Hörkkö; Carol Forsblom; Per-Henrik Groop; Markku Lehto; Peter Rossing
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

2.  Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) modulates T1DM susceptibility by gut microbiota.

Authors:  Yang-Yang Li; James A Pearson; Chen Chao; Jian Peng; Xiaojun Zhang; Zhiguang Zhou; Yu Liu; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2017-06-04       Impact factor: 7.094

3.  Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus.

Authors:  John S Leeds; Marios Hadjivassiliou; Solomon Tesfaye; David S Sanders
Journal:  BMJ Open Diabetes Res Care       Date:  2018-05-29

Review 4.  The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders.

Authors:  Markku Lehto; Per-Henrik Groop
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-19       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.